Aveni Foundation is committed to expediting development of gene-targeted therapies for cancer, Parkinson’s disease, and other unmet medical needs.

Cancer is a leading cause of death worldwide, accounting for 10 million deaths in 2020, or nearly one in six deaths (World Health Organization, 2022). More than 10 million people worldwide are living with Parkinson’s disease (Parkinson’s Foundation, 2022). It is our mission to support the timely development of innovative targeted therapies for cancer and Parkinson’s disease.

The foundation is named in honor of Fr. Joseph Aveni, RCJ, a Rogationist priest who experienced significant clinical benefit from DeltaRex-G, a gene targeted therapy (Intl J Oncol 36:1341-1353, 2010), and whose cause of canonization is ongoing.

CONTACT

2811 Wilshire Blvd #420
Santa Monica, CA 90403 info@avenifoundation.org